Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus.

Ilaria CavazzanaR KumarC PozzariR OttavianiM FrediS PiantoniLaura AndreoliA TincaniF Franceschini

Published in: Lupus (2019)

Belimumab treatment induced a significant reduction of SLE-specific autoantibodies titre and IgM anti-β2GPI. Anti-ribosomal titre decrease correlates with anti-dsDNA titre and disease activity improvement.

Keyphrases

systemic lupus erythematosus
disease activity
rheumatoid arthritis
rheumatoid arthritis patients
ankylosing spondylitis
juvenile idiopathic arthritis
high glucose
diabetic rats